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A CONTINUOUS STRAIN-SPACE MODEL OF VIRAL
EVOLUTION WITHIN A HOST
ANDREI KOROBEINIKOV AND CONOR DEMPSEY
Abstract. Viruses rapidly evolve, and HIV in particular is known to be one
of the fastest evolving human viruses. It is now commonly accepted that viral
evolution is the cause of the intriguing dynamics exhibited during HIV infec-
tions and the ultimate success of the virus in its struggle with the immune
system. To study viral evolution, we use a simple mathematical model of the
within-host dynamics of HIV which incorporates random mutations. In this
model, we assume a continuous distribution of viral strains in a one-dimensional
phenotype space where random mutations are modelled by diffusion. Numeri-
cal simulations show that random mutations combined with competition result
in evolution towards higher Darwinian fitness: a stable traveling wave of evo-
lution, moving towards higher levels of fitness, is formed in the phenotype
space.
1. Introduction
Compared with many viruses, HIV has unusually high genetic variability within
individual hosts and is one of the fastest known evolving entities [7, 22, 23, 62].
This diversity and rapid evolution is the cumulative effect of a combination of
several factors. Firstly, HIV replicates remarkably fast; when viral loads for
HIV are very high in acute or chronic untreated infection, up to 1010–1012 new
virions can be generated every day [52, 53]. This is coupled with a high rate
of mutation of approximately 3·10−5 per nucleotide base per cycle of replication
and recombinogenic properties of reverse transcriptase [39, 56]. Furthermore,
HIV has one of the highest recombination rate of all organisms, with about three
recombinations per genome per replication cycle on average [37, 29, 73]. This
further increases diversity and, eventually, the rate of evolution. These factors in
combination result in the generation of many variants of HIV in a host during a
single day [56]. The diversity and the ability of HIV to evolve within and among
hosts is recognized as a major factor influencing HIV dynamics [71, 40, 62]. The
ability to evolve enables the virus to escape from CTL responses [2, 3, 12, 19, 54],
leads to development of drug-resistent strains making its treatment extremely
difficult [18, 21] and prevents development of an effective vaccine [9, 33, 50].
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Certain questions arise when considering intra-host genetic variation and evo-
lution. The first question is what is the driving force behind this evolution?
Although it was suggested that genetic drift (that is, stochastic effects) could be
responsible for evolution [15], there is strong evidence that the intra-host evo-
lution is mostly driven by positive natural selection [56, 68]. Another question
is about the role of immune selection pressure, which could be generated via a
number of mechanisms, such as by neutralizing antibodies [3, 9] in this natural
selection [56]. It is also not clear how evolution is linked to the development of
AIDS [56]. A commonly accepted hypothesis is suggested that increasing diversity
leads to an exhaustion of the immune system which, as a result, fails to suppress
each emerging variant as well as opportunistic infections [44]. Answering these
questions will allow us to better predict the long-term spread of drug resistance
and CTL-escape mutations, as well as the likely impact of vaccination [56].
In this notice we mathematically model within-host dynamics of HIV with an
aim to address these questions. We use a simple deterministic model of the within-
host virus dynamics where a possibility for random mutations is incorporated;
simulations with this model demonstrate that random mutations combined with
competition result in evolution towards higher Darwinian fitness.
2. Model
The usual approach to the study of viral evolution is to employ multi-strain
models; these models were successfully applied for both intra-host [44, 24, 63]
and inter-host evolution [6, 5, 11, 13, 17, 38, 51]. Multi-strain models explicitly
assume the existence of a discrete [44, 17, 61] or continuous [38, 65, 20, 59] set
of viral strains, which form a discrete or continuous strain space (also known as
variant space, phenotype space, or fitness space); among other advantages, the
concept of strain space allows to introduce a distance between strains [11, 13, 17].
The strains are either predetermined [24, 63, 6, 5], and no new strains can appear
in this case, or emergence of new strains is assumed due to random mutations.
Random mutations can be modelled by diffusion [38, 65, 20, 59] or its finite-
difference equivalent [17, 61] in the strain space; mutations also can be directly
described by a stochastic process [44].
Tsimring et al. [65] considered viral evolution using a model where random mu-
tations are described by diffusion in a one-dimensional continuous fitness space.
The model exhibits a solution in the form of a pulse-type traveling wave of evo-
lution. An apparent shortcoming of Tsimring et al. model and the result is that
the model is not derived from biologically motivated hypotheses or assumptions
but is, instead, an equation with the expected dynamics: the model equation,
apart from the diffusion term which is used to model random mutations, have no
visible biological interpretation. A modification of this model was constructed by
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Saldan˜a et al. [59], who considered a Lotka-Volterra model with distributed com-
petition in a one-dimensional continuous fitness space and with random mutation
defined by diffusion.
Sasaki [60], Haraguchi and Sasaki [20], and Sasaki and Haraguchi [61] studied
co-evolution of a pathogen and an immune response (antigen drift) within a host
using a pathogen-antibodies model with a discrete or continuous one-dimensional
strain space. In these studies, all strains were assumed equal and are not inter-
acting in any way; these assumptions made a positive selection or an increase of
fitness meaningless in this model framework. This model shows the evolution of
antigen variants in the form of a pulse traveling wave in the strain space; on this
basis, the authors came to a conclusion that the antigenic drift, by which the
pathogen can continuously escape the immune defence, is driven by immune re-
sponse. We have to note, however, that the pulse wave observed in these studies
is a result of superposition of two distinct traveling waves, both of each are of
a standard Kolmogorov-Fisher type [32]. The first of these two waves describes
the spread of pathogen by diffusion; this wave is followed by the wave of specific
immune response, which wipe the pathogen out.
To study inter-host antigenic drift, Lin et al. [38] generalized the classical SIR
model by including mutation as a diffusion process in a one-dimensional contin-
uous phenotype space. The major difference between this model and Sasaki’s
model is that Lin et al. introduced a cross-immunity between the near strains
(which is a very important development). This model also exhibits traveling
wave solutions. An apparent deficiency of this model is that the strains are of
the same level of fitness and that they interact only via cross immunity, and hence
there can be no positive selection in this model either. In absence of the cross
immunity, the model exhibits a traveling wave of Kolmogorov-Fisher type.
As a basis for this study, we begin with the simplest virus dynamics model that
is due to Anderson and May [4], Nowak and May [46] and Wodarz et al. [70]:
du(t)
dt
= b− βu(t)v(t)− du(t),
dv(t)
dt
= βu(t)v(t)−mv(t).(1)
Here, u(t) and v(t) are populations of healthy (uninfected) and infected target
cells, respectively. The uninfected target cells (in the case of HIV these are CD4+
T cells) are assumed to be produced at a constant rate b, and their natural death
rate is d; that is, the average life span of a healthy cell is 1/d. Infected cells die at
a rate mv. Susceptible cells are infected by free virus produced by infected cells.
In this model, population of free virus is implicitly assumed to be proportional
to the population of infected cells. This assumption is justified when the time
scale of free virus is much faster than that of the host cells, as in this case the
free virus population quickly converges to a quasi-equilibrium level proportional
to the infected cell population [27, 69, 66]. Hence, the rate of infection is βuv.
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The properties of this model are well-studied (see e.g. [66, 34, 35]). The generic
properties of this model are entirely determined by the basic reproduction number
of the infected sells R0 = bβ/dm. The model always has an infection-free equi-
librium state Q0, where u = b/d and v = 0. When R0 ≤ 1, this equilibrium state
is the only equilibrium state of the system and is globally asymptotically stable
(that is, for any non-negative initial conditions the system eventually converge
to the equilibrium state). If R0 is larger than 1, then Q0 losses its stability, and
the model has a positive (endemic) globally stable equilibrium state Q∗, where
both populations coexist.
Using model (1) as a basis, we assume now that viral strains form a continuous
strain space. New strains emerge as a result of random mutations, which in the
continuous strain space can be modelled by diffusion. For simplicity we limit our
consideration to a 1-dimensional strain space M = {s ∈ [0,∞)}. Then v(t, s)
is the distribution of the infected population in the strain space, and the total
infected population is V (t) =
∫∞
0
v(t, s)ds. In the model (1) framework, a strain
is characterized by parameters β and m. For the sake of simplicity, we assume
that m is the same for all strains, whereas β is a function of s; we assume in this
paper that β(s) = as (where a > 0). Thus, the basic reproduction number of
virus R0 = bβ/dm = bas/dm is proportional to s, and s serves as a measure of
fitness. These assumptions lead to the following equations:
du(t)
dt
= b− u(t)
∫ ∞
0
β(s)v(t, s)ds− du(t),
∂v(t, s)
∂t
= β(s)u(t)v(t, s)−mv(t, s) + µ∂
2v(t, s)
∂s2
.(2)
The natural boundary condition for v(t, s) at s = +∞ is zero. The choice of a
condition at s = 0 is not obvious; for convenience we use the condition ∂v(t,0)
∂s
= 0.
The system (2) should be complemented by non-negative initial conditions u0 =
u(0) and v0(s) = v(0, s).
The variable u is measured in cells·mm−3; v is the density of cells in the strain
space, and hence it is measured in cells·s−1·mm−3. The cell production rate b
is measured in cells·mm−3·day−1; m and d are measured in day−1, and β is in
cells−1·day−1. We postulated above that β ∼ s, and hence s is measured in
cells−1·day−1, and µ in cells−2·day−3.
3. Results
Figures 1 to 4 show results of numerical simulations of equations (2). In
this simulations, we use parameter values for patient 2 in [25, 64]: b = 20
cells·mm−3·day−1, m = 0.8 day−1 and d = 0.02 day−1. For convenience of presen-
tation, we take a =10−3; that yields β(s) = s/1000, and, recalling that for these
parameters the infection-free level of uninfected cells is u0 = 1000 cells·mm−3,
the basic reproduction number R0 = βu0/m = s/m. In simulations we use the
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diffusion coefficient µ equal to 10−8, 10−7 and 10−6 cells−2·day−3; for µ ≈ 5 ·10−7,
CD4+ T cells level reached 200 cells·mm−3 in roughly 10 years, which corresponds
to clinical observations [46, 1] and thus mimics the real-life progression of an in-
fection. (However, this does not implies that the real-life coefficient is equal to
5 · 10−7, as immune response, which is not included in model (2), can have a
considerably effect on viral evolution and on all-over disease progression.)
To mimic a real life situation, we assume that the initial virus load is very
low and composed of a very narrow band of strains. In Figures 1 to 4 the initial
distribution is (see Fig. 3(a)):
v(0, s) =

8(s− 0.9975) for 0.9975 ≤ s < 1.0,
0.02 for 1.0 ≤ s ≤ 1.005,
8(1.0075− s) for 1.005 < s ≤ 1.0075,
0 otherwise.
We have to note, however, that changes in magnitude or dispersion of initial dose
has a very small effect on the long term dynamics. Thus, for a relatively wide
initial distribution, it is the uppermost non-zero end of the distribution that only
matters, whereas the rest of the initial interval relatively quickly disappears. (It
is noteworthy, that the same effect was observed by Tsimring et al. [65], who
misinterpreted this effect and even introduced a cut-off to avoid it.)
Figure 1 shows the distribution of infected cells in the phenotype space for 10
years for µ = 10−6; formation of a pulse traveling wave, which moves towards
higher levels of fitness (larger s) in the strain space, is clearly seen in the Fig-
ure. This shows that random mutations (which are described by diffusion in the
model), in combination with competition for a “resource” (uninfected target cells
in this case) leads to viral evolution. This result also shows that immune response
is not essential for evolution.
An intriguing feature of evolution in Fig. 1 is that the speed of the traveling
wave (speed of evolution) is not constant. (This also can be seen in Figures 2 and
4, which show the dynamics of uninfected and infected populations.) Figures 1
and 2 show that the speed of evolution depends on both the fitness (infectivity in
this case) of the strains and the abundance of uninfected target cells: the speed
of evolution steadily grows with the growth of the infectivity until the level of the
uninfected cells drops below a certain threshold; after this moment evolution slows
and its speed remains approximately constant. In Figures 1, where µ = 10−6, this
slow-down occurs at about 6.7 years; for smaller µ this change of the dynamics
occurs later and is even more evident (see curves for µ = 10−7 and 10−8 in Fig. 2).
For relatively low µ (e.g. for µ = 10−8 in Fig. 2), the varying speed of evolution
leads to the dynamics which has close qualitative resemblance with the typical
progression of HIV infection. In Fig. 2, a relatively short transition period is
followed by a longer period of slow evolution, when the level of uninfected CD4+ T
cells is decreasing very slowly. This period, which is resembling the asymptomatic
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stage of HIV infection, ends with a comparatively fast acceleration of evolution
and a fast drop of the uninfected CD4+ T cells level; this can be associated with
the abrupt drop of the CD4+ T cells level at the end of the asymptomatic stage
and the development of AIDS.
Numerical simulations show that the evolution leads to an increase of viral
diversity; Figure 3(b) shows distributions of the infected population in the strain
space after 10 years of evolution for µ = 10−6, 10−7 and 10−8. However, this
increase of diversity is lower than it can be expected. Moreover, distribution
after 10 years is almost independent from an initial distribution.
Figure 1. Distribution of the infected cells population in the phe-
notype space for 10 years. Please note formation of a pulse-type
traveling wave of evolution and the variable speed of the wave.
Here, b = 20 cells·mm−3·day−1, m = 0.8 day−1, d = 0.02 day−1,
a = 10−3 and µ = 10−6cells−2·day−3.
4. Discussion and Conclusion
The aim of this study was mathematical modelling of within-host evolution of
HIV. We suggest and consider a mathematical model of the within-host dynamics
of HIV, which is an extension of the Nowak-May model of virus dynamics in vivo,
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Figure 2. The dynamics of the uninfected CD4+ T cells levels for
10 years for µ = 10−6, 10−7 and 10−8.
where viral strain are assumed to be continuously distributed in a 1-dimensional
phenotype space and a possibility of random mutation of the virus is incorporated.
Numerical simulations with this model demonstrated that random mutations
combined with competition for a resource (the target cells in this case) result in
evolution towards higher Darwinian fitness.
Numerical simulations show that the speed of evolution is not constant but
depends on the infectivity of strains and the abundance of target cells. For
relatively low values of the diffusion coefficient, this dependence leads to the
dynamics which is qualitatively very similar to the typical dynamics of HIV in-
fection: following the transition period, there is a prolonged period of relatively
slow evolution (and a slow decreasing of the CD4+ T cells level), which follows
by a period of a fast acceleration of evolution (and hence by an abrupt drop of
the CD4+ T cells level). This dynamics is very similar to the asymptomatic stage
of HIV infection, which ends with a rapid drop of the CD4+ T cells level and a
development of AIDS.
Immune response is not included in the model, and the results demonstrate
that this is not necessary for evolution. This, however, does not mean that the
immune response have no impact on evolution at all. On contrary, based on the
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Figure 3. Distribution of infected cells in the strain space; here
(a) is the initial distribution, and (b) are distributions after 10
years for µ = 10−8, 10−7 and 10−6. Please note different vertical
scales in (a) and (b).
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Figure 4. The dynamics of infected population (a) and the infec-
tive force (b) for 10 years for µ = 10−8, 10−7 and 10−6.
analysis of the results, one can come to a conclusion that, if immune response
does not eliminate virus, then it increases the speed of evolution. Simulations
show that the speed of evolution directly depends on the abundance of the target
cells, and therefore a possible mechanism of this increase of speed of evolution
due to immune response is not a positive selection (even if this can make an effect
as well) but rather reducing competing pressure on newly emerging strains and
thus, by eliminating earlier emerged less fit strains, providing more target cells
for more fit strains.
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